Merit Financial Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
CGH
CNB
AP
Merit Financial Group's GILD Position: Q2 2026 in Review
Merit Financial Group reduced its Gilead Sciences (GILD) stake by 5.6% in Q2 2026, selling an estimated $451K and leaving 57,490 shares worth $7.26M. The position accounts for 0.04% of the portfolio, ranked #333.
Merit Financial Group first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $8.49M in Q1 2026. 494 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Merit Financial Group held 57,490 shares of Gilead Sciences worth $7.26M as of Q2 2026.
- Merit Financial Group sold 3,424 Gilead Sciences shares in Q2 2026, an estimated $451K.
- Gilead Sciences made up 0.04% of Merit Financial Group's portfolio in Q2 2026, its #333 holding.
- Merit Financial Group first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
- Merit Financial Group's Gilead Sciences position peaked at $8.49M in Q1 2026.
- 494 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.